Answer
Yes, thiotepa is a known human carcinogen associated with an increased risk of secondary malignancy, and this risk must be explained to the patient.
Sources for this answer
- Thiotepa Riemser 15 mg powder for concentrate for solution for infusionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked